Morten Herholdt
Stock Analyst at HSBC
(1.47)
# 2,605
Out of 4,667 analysts
17
Total ratings
44.44%
Success rate
-9.82%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $237.85 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $175.67 | +28.08% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $156.00 | +119.23% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $88.63 | -22.15% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $153.11 | +11.03% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $2.31 → $1.02 | $0.30 | +236.63% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $600.50 | -10.07% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $50.05 | +3.90% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $194.38 | +33.76% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $287.87 | +11.16% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.39 | +734.53% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $237.85
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $175.67
Upside: +28.08%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $156.00
Upside: +119.23%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $88.63
Upside: -22.15%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $153.11
Upside: +11.03%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $2.31 → $1.02
Current: $0.30
Upside: +236.63%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $600.50
Upside: -10.07%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $50.05
Upside: +3.90%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $194.38
Upside: +33.76%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $287.87
Upside: +11.16%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.39
Upside: +734.53%